Science Explorer Back to mapMap
Discussion
Company · Gaithersburg · United States

MaxCyte (United States)

maxcyte.comROR OpenAlex
Research works
34
▼ 32% vs 2018-21
Citations
637
18.8 per fractional work
Top-10% rate
12.1%
all institutions 10.0%
Open access
36%
world 40%
International
20%
world 18%
MaxCyte (United States)

Not ranked overall: MaxCyte (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does MaxCyte (United States) work in?

In all years, 62% of research at MaxCyte (United States) is in Life Sciences, 30% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (46%), Medicine (30%), Immunology and Microbiology (15%). It does 3.0× the world's share of Life Sciences.

Life Sciences: 21 fractional works · 62.5% of its workBiochemistry, Genetics and Molecular Biology: 16 fractional works · 46.1% of its workMolecular Biology: 8 fractional works · 24.6% of its workGenetics: 4 fractional works · 11.9% of its workBiotechnology: 3 fractional works · 9.1% of its workAging: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 5 fractional works · 14.5% of its workImmunology: 5 fractional works · 14.5% of its workAgricultural and Biological Sciences: 0 fractional works · 1.1% of its workAnimal Science and Zoology: 0 fractional works · 0.3% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.3% of its workInsect Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 0.7% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.7% of its workHealth Sciences: 10 fractional works · 30.1% of its workMedicine: 10 fractional works · 30.1% of its workOncology: 6 fractional works · 17.9% of its workGenetics: 1 fractional works · 2.7% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.6% of its workEpidemiology: 0 fractional works · 1.3% of its workInfectious Diseases: 0 fractional works · 1.3% of its workPhysiology: 0 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.0% of its workPathology and Forensic Medicine: 0 fractional works · 0.8% of its workSurgery: 0 fractional works · 0.8% of its workNeurology: 0 fractional works · 0.6% of its workHematology: 0 fractional works · 0.3% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.3% of its workReproductive Medicine: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 0.0% of its workPhysical Sciences: 2 fractional works · 6.4% of its workEngineering: 2 fractional works · 4.4% of its workBiomedical Engineering: 1 fractional works · 4.0% of its workElectrical and Electronic Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEnvironmental Science: 0 fractional works · 1.0% of its workEcology: 0 fractional works · 1.0% of its workMathematics: 0 fractional works · 1.0% of its workStatistics and Probability: 0 fractional works · 1.0% of its workSocial Sciences: 0 fractional works · 1.0% of its workSocial Sciences: 0 fractional works · 0.5% of its workHealth: 0 fractional works · 0.2% of its workSociology and Political Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.3% of its workEconomics and Econometrics: 0 fractional works · 0.3% of its workPsychology: 0 fractional works · 0.2% of its workClinical Psychology: 0 fractional works · 0.2% of its workALL ITS WORKMaxCyte (UnitedStates)34fractional works, all years
Life Sciences62%Physical Sciences6%Health Sciences30%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1646.1%
    2. Immunology and Microbiology514.5%
    3. Agricultural and Biological Sciences01.1%
    4. Neuroscience00.7%
    1. Medicine1030.1%
    2. Health Professions00.0%
    1. Engineering24.4%
    2. Environmental Science01.0%
    3. Mathematics01.0%
    1. Social Sciences00.5%
    2. Economics, Econometrics and Finance00.3%
    3. Psychology00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.13× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 12.57× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 7.89× its world share, 0 worksImmunology and Micro…Engineering: 0.10× its world share, 0 worksEngineeringMedicine: 1.10× its world share, 1 worksMedicineEconomics, Econometrics and Finance: 0.83× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 12.6×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology12.57×4 works
  2. Immunology and Microbiology7.89×0 works
  3. Medicine1.10×1 works
  4. Economics, Econometrics and Finance0.83×0 works
  5. Agricultural and Biological Sciences0.13×0 works
  6. Engineering0.10×0 works

Who are the top researchers at MaxCyte (United States)?

Ranked on the quality score, Linda N. Liu, Madhusudan V. Peshwa and Linhong Li lead among researchers whose main affiliation is MaxCyte (United States).

  1. 1 Linda N. Liu United States · #714,037 worldwide 2.5k citations · 84 works
  2. 2 Madhusudan V. Peshwa United States · #811,936 worldwide 3.3k citations · 72 works
  3. 3 Linhong Li United States · #976,870 worldwide 1.6k citations · 61 works
  4. 4 Sergey M. Dzekunov United States · #1,608,501 worldwide 2.2k citations · 16 works
  5. 5 Rama Shivakumar United States · #1,890,901 worldwide 685 citations · 21 works
  6. 6 Cornell Allen United States · #2,560,390 worldwide 906 citations · 41 works
All ranked researchers at MaxCyte (United States)

What are the most cited papers from MaxCyte (United States)?

The most cited paper from MaxCyte (United States) is "CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease" (Suk See De Ravin, Linhong Li, Xiaolin Wu et al., 2017), with 262 citations. Next come "Targeted gene addition in human CD34+ hematopoietic cells for correction of X-linked chronic granulomatous disease" (195) and "Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method" (141).

Most cited papers
#PaperReleasedCitations
1 CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease Suk See De Ravin, Linhong Li, Xiaolin Wu et al. · Science Translational Medicine 11 Jan 2017 262
2 Targeted gene addition in human CD34+ hematopoietic cells for correction of X-linked chronic granulomatous disease Suk See De Ravin et al. · Nature Biotechnology Open access 7 Mar 2016 195
3 Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method Lin Li, L N Liu, Stephanie Feller et al. · Cancer Gene Therapy Open access 11 Sep 2009 141
4 Selective Field Effects on Intracellular Vacuoles and Vesicle Membranes with Nanosecond Electric Pulses Ephrem Tekle, Hammou Oubrahim, Sergey M. Dzekunov et al. · Biophysical Journal Open access 8 Apr 2005 137
5 Efficient mRNA-Based Genetic Engineering of Human NK Cells with High-Affinity CD16 and CCR7 Augments Rituximab-Induced ADCC against Lymphoma and Targets NK Cell Migration toward the Lymph Node-Associated Chemokine CCL19 Mattias Carlsten, Emily Ruth Levy, Amrita D. Karambelkar et al. · Frontiers in Immunology Open access 21 Mar 2016 119
All 78 most cited papers, with filters and sorting

Which keywords describe research at MaxCyte (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Gene Therapy, Immunotherapy, Lymphoma, Leukemia, Tumor Regression, CAR T Cells and Chimeric Antigen Receptor.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 33 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 33 words, with their numbers
  1. Cancer Immunotherapy8▲ 158×3 topics
  2. Gene Therapy7▲ 78×4 topics
  3. Immunotherapy6▲ 27×5 topics
  4. Lymphoma6▲ 119×3 topics
  5. Leukemia6▲ 259×2 topics
  6. Tumor Regression6▲ 193×2 topics
  7. CAR T Cells6▲ 378×1 topic
  8. Chimeric Antigen Receptor6▲ 378×1 topic
  9. Genome Engineering4▲ 216×1 topic
  10. RNA-Guided4▲ 216×1 topic
  11. Genomic Integration4▲ 110×2 topics
  12. AAV4▲ 168×1 topic
  13. Viral Vectors4▲ 168×1 topic
  14. Immunity3▲ 23×3 topics
  15. Innate Immunity2▲ 18×2 topics
  16. Antigen Presentation2▲ 55×1 topic
  17. Dendritic Cells2▲ 48×1 topic
  18. Glycosylation2▲ 24×2 topics
  19. Electroporation2▲ 231×1 topic
  20. Irreversible Electroporation2▲ 231×1 topic
  21. RNA Interference2▲ 39×1 topic
  22. siRNA Delivery2▲ 58×1 topic
  23. Biopharmaceutical Production1▲ 54×2 topics
  24. Cell Culture1▲ 36×2 topics
  25. Monoclonal Antibody1▲ 59×2 topics
  26. Mammalian Cells1▲ 96×1 topic
  27. NK Cell Recognition1▲ 38×1 topic
  28. Natural Killer Cells1▲ 38×1 topic
  29. Recombinant Protein1▲ 96×1 topic
  30. Plant Molecular Farming1▲ 149×1 topic
  31. Recombinant Proteins1▲ 68×1 topic
  32. Autoimmunity1▲ 15×2 topics
  33. Rituximab1▲ 19×2 topics

Which research topics does MaxCyte (United States) publish most on?

By volume in 2022-now: CRISPR and Genetic Engineering, CAR-T cell therapy research, Virus-based gene therapy research and Viral Infectious Diseases and Gene Expression in Insects.

CRISPR and Genetic Engin…1CRISPR and Genetic Engineering: 1 fractional worksCAR-T cell therapy research: 1 fractional worksVirus-based gene therapy research: 1 fractional worksViral Infectious Diseases and Gene Expression in Insects: 0 fractional worksTransgenic Plants and Applications: 0 fractional worksImmune Cell Function and…0Immune Cell Function and Interaction: 0 fractional worksCancer-related Molecular Pathways: 0 fractional worksWnt/β-catenin signaling in development and cancer: 0 fractional worksT-cell and B-cell Immunology: 0 fractional worksGenomic variations and chromosomal abnormalities: 0 fractional works
Molecular BiologyOncologyGeneticsBiotechnology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CRISPR and Genetic Engineering Molecular Biology 1 works
  2. 2 CAR-T cell therapy research Oncology 1 works
  3. 3 Virus-based gene therapy research Genetics 1 works
  4. 4 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  5. 5 Transgenic Plants and Applications Biotechnology 0 works
  6. 6 Immune Cell Function and Interaction Immunology 0 works
  7. 7 Cancer-related Molecular Pathways Oncology 0 works
  8. 8 Wnt/β-catenin signaling in development and cancer Molecular Biology 0 works
  9. 9 T-cell and B-cell Immunology Immunology 0 works
  10. 10 Genomic variations and chromosomal abnormalities Genetics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.5%not open64.5%

World: 40% of research is openly available.

with international co-authors19.8%domestic only80.2%

World: 18% is written across borders.

How has MaxCyte (United States)'s research output changed?

Output in 2022-2025 was 32% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is MaxCyte (United States) as a percentage of every work published that year, 0.000015% in 2024.

still counting0.000050%0.00010%0.00015%MaxCyte (United States)0.0000099% in 202520102020

Fractional works of MaxCyte (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Gaithersburg

All research institutions in Gaithersburg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about MaxCyte (United States). Posts are plain text and can be reported.